8-K - Century Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On January 7, 2026, Century Therapeutics, Inc. (the “Company”), entered into a securities purchase agreement (the “P

Material Agreement

$1.15$1.15$2.60$2.60

Source Document

3.02

. The Shares, Pre-Funded Warrants and Common Warrants were sold without registration under the Securities Act, in reliance on the exemptions provided by Section

Securities Issuance

7.01

Regulation FD Disclosure. On January 8, 2026, the Company issued a press release announcing the Private Placement. The full text of the press release issued in

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits 4.1 Form of Pre-Funded Warrant 4.2 Form of Common Warrant 10.1 Securities Purchase Agreement, dated January 7, 2

Exhibits Only

Source Document

Exhibits (7)

10.1

EXHIBIT 10.1

10.2

EXHIBIT 10.2

4.1

EXHIBIT 4.1

4.2

EXHIBIT 4.2

8-K

FORM 8-K

99.1

EXHIBIT 99.1

99.2

EXHIBIT 99.2